Carl Zeiss Meditec AG

$27.24

$0.05(-0.17%)

Carl Zeiss Meditec AG

AFX.DE

$27.24

$0.05(-0.17%)

Carl Zeiss Meditec AG

AFX.DE

XETRA

$27.24

$0.05(-0.17%)

Chart

Upcoming Earnings

Next report date

May 12, 2026

Report period

Q2 2026

EPS Estimate

$0.24

Revenue Estimate

$602.14M

Key stats

52-Week Range$27.24

$26.60

$82.07

Market capitalization

$2.37B

Dividend yield (indicated)

2.49%

Price to earnings Ratio (TTM)

14.94

Basic EPS (TTM)

$2.23

Net income (TTM)

$161.76M

Revenue (TTM)

$2.55B

Avg. volume

352.82K

Beta (1Y)

1.41

Employees

2.07K

Market capitalization

$2.37B

Dividend yield (indicated)

2.49%

Price to earnings Ratio (TTM)

14.94

Basic EPS (TTM)

$2.23

Net income (TTM)

$161.76M

Revenue (TTM)

$2.55B

Avg. volume

352.82K

Beta (1Y)

1.41

Employees

2.07K

Screener Quick Check

About Carl Zeiss Meditec AG

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Andreas Pecher

Website

www.zeiss.de

Headquarters

Goschwitzer Strasse 51-52, Jena, 07745

IPO Date

2000-03-22

Identifiers

ISINDE0005313704

Description

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the...

Related Stocks

Fielmann AG

FIE.DE

$48.57Mkt Cap: $4.08B

Healthcare

Medical - Instruments & Supplies

ISIN:DE0005772206

BB Biotech AG

BBZA.DE

$58.08Mkt Cap: $3.20B

Healthcare

Biotechnology

ISIN:CH0038389992

Dividend Overview

Dividend yield (indicated)

2.49%

Dividend per share

$0.69annual

Payout ratio (Earnings)

37.2%

Payout ratio (FCF)

36.4%

Dividend growth streak

Dividend CAGR (3Y)

-28.3%

Dividend CAGR (5Y)

-4.1%

Dividend CAGR (10Y)

+0.6%

Dividend yield (indicated)

2.49%

Dividend per share

$0.69annual

Payout ratio (Earnings)

37.2%

Payout ratio (FCF)

36.4%

Dividend growth streak

Dividend CAGR (3Y)

-28.3%

Dividend CAGR (5Y)

-4.1%

Dividend CAGR (10Y)

+0.6%

Financials

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate

Performance

Margin trends

Debt level and coverage

Earnings

Next: Q2 '26

Actual

Estimate

Earnings

Next: Q2 '26

Actual

Estimate